Parkinson's Disease: Are PINK1 Activators Inching Closer to the Clinic?

Published in: ACS medicinal chemistry letters (2023)

The activation of PINK1 by small molecules has emerged as a promising strategy in treating Parkinson's disease (PD). Recent progress in this area has raised excitement around PINK1 activators as PD treatments, and herein we offer insight into these developments and their potential to deliver much needed novel PD treatments.

Keyphrases

primary care
risk assessment
human health